Hangzhou Tigermed Consulting (03347) repurchased 1.5507 million shares at a cost of 60.0656 million yuan on June 10th.

Hangzhou Tigermed Consulting (03347) announced that on June 10, 2026, the company, for the first time, repurchased 1.5507 million shares of its own stock through a stock repurchase dedicated securities account via centralized bidding trading method. This represents 0.1801% of the company's current total share capital and 0.2102% of its current A-share total share capital. The highest transaction price was 39.50 yuan/share and the lowest transaction price was 38.22 yuan/share, resulting in a total transaction amount of 60.0656 million yuan (excluding transaction costs). This repurchase complies with the company's share repurchase plan and relevant laws and regulations.